NanoAssemblr™ Chosen for Horizon 2020 Project to Develop Novel RNA therapeutics

Product News   Mar 29, 2017 | Original story from Precision Nanosystems

 
NanoAssemblr™ Chosen for Horizon 2020 Project to Develop Novel RNA therapeutics

Credit: Precision NanoSystems

 
 
FURTHER INFORMATION
 
 
 

Related Product News

ReForm Biologics Announces New Patent for Antibody-Based Therapeutics

Product News

New surfactant replacement offers a promising alternative to polysorbates for stabilizing proteins.

READ MORE

Ultivue launches UltiMapper™ Portfolio of Reagents

Product News

Ultivue has announced the public launch of its UltiMapper™ portfolio of reagents enabling the highest throughput of whole-slide, protein biomarker spatial detection and analysis in tissue, at high level of multiplexing, using instrumentation and software solutions currently found in most Immuno-Histochemistry laboratories.

READ MORE

New England Biolabs® Launches NEBNext Direct® Custom Ready Panels for Efficient Targeted Re-sequencing

Product News

Library of ~850 pre-synthesized gene targets and novel target enrichment technology supports rapid customization across a variety of panel sizes and content.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy